<DOC>
	<DOCNO>NCT00111072</DOCNO>
	<brief_summary>This study evaluate effectiveness dexamethasone 0.01 % solution treat pain associate oral lichen planus , chronic disease cause painful ulcer inside mouth . The cause lichen planus know , may relate allergic immune reaction . This study examine cause disease , pain associate , impact patient ' life use dexamethasone treat . Patients 12 old severe oral lichen planus may eligible study . Candidates screen blood test biopsy confirm diagnosis provide tissue research purpose . For biopsy , two small circle tissue , 4 mm ( 1/5 inch ) across , surgically remove . Participants randomly assign rinse mouth either dexamethasone solution placebo ( rinse active ingredient ) four time day 4 week . During period may use oral topical pain anti-inflammatory medication except diphenhydramine 12.5 mg/5 ml ( topical numbing medicine ) Tylenol , provide study . Patients come NIH Clinical Center three 1-hour visit ( every two week ) 4 week study medication stop . At first three visit patient submit pain diary record information pain level , check medication side effect . On third visit ( last day take study drug ) also test adrenal suppression may result take steroid rinse . For test give injection drug call synacthen 1 hour , blood sample drawn . Patients return final visit 1 month later determine disease return improve medication stop .</brief_summary>
	<brief_title>Dexamethasone Treat Oral Lichen Planus</brief_title>
	<detailed_description>This study pain , oral function salivary biomarkers oral lichen planus . The primary objective study determine efficacy dexamethasone rinse reduce pain patient oral lichen planus . Secondary objective evaluate novel score system severity lichen planus , assess change salivary biomarkers associate treatment , assess impact oral lichen planus quality life use SF-36 instrument Oral Health Impact Profile ( OHIP-14 ) . This double-blind parallel group design 20 patient arm . Our primary outcome measure change visual analog scale assess pain . We consider decrease 30 mm clinically significant . Secondary outcome include reduction oral symptom measure OHIP-14 , amount topical analgesic use , improvement quality life score , severity lesion assess two scale . A new oral lichen planus score system evaluate validity , reliability sensitivity change . This system quantify severity amount oral lichen planus lesion scale 0 66 . Validation scale need future study oral lichen planus . The validity sensitivity change assess correlation score patient base outcomes well global scale . Inter- intra-rater reliability also test . The principal study intervention dexamethasone 0.01 % oral rinse identical appearance taste placebo rinse . Additional allow intervention standard oral topical analgesic rinse acetaminophen need basis . Diagnostic research evaluation include complete history oral general physical examination , laboratory investigation , saliva collection , oral mucosal biopsy . The interventional period trial 4 week .</detailed_description>
	<mesh_term>Lichen Planus , Oral</mesh_term>
	<mesh_term>Lichen Planus</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>INCLUSION CRITERIA : Biopsy confirm symptomatic oral lichen planus . World Health Organization histological criterion ( 12 ) combination compatible clinical appearance use diagnosis . No current treatment immunomodulatory agent . A onemonth washout period require prior enrollment patient take immunomodulatory agent . Prior treatment topical steroid allow provide presence symptomatic lesion . Age great 12 year old . Lichen planus rare patient young 40 year old . Patients must rinse spit medication rather swallow . Oral rinse topical fluoride recommend young child . Patients sexes racial ethnic group eligible . Symptomatic lichen planus score least 35 mm visual analog scale pain . Oral lichen planus score least 3 lichen planus severity scale . EXCLUSION CRITERIA : Unable undergo oral biopsy diagnosis . Asymptomatic lichen planus ulcerate erythematous oral lesion . Treatment immunomodulatory agent within 1 month randomization . Hepatitis C infection . Documented hypersensitivity dexamethasone . Pregnancy lactation . Poorly control diabetes . Inability unwillingness give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>Mucosal Disease</keyword>
	<keyword>Topical Steroids</keyword>
	<keyword>Salivary Diagnostics</keyword>
	<keyword>Oral Pain</keyword>
	<keyword>Quality Life Indicators</keyword>
	<keyword>Oral Lichen Planus</keyword>
</DOC>